missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human LEPRE1 (aa 156-290) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (93%), Rat (93%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-53527 (PA5-53527. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Basement membrane-associated chondroitin sulfate proteoglycan (CSPG). Has prolyl 3-hydroxylase activity catalyzing the post-translational formation of 3-hydroxyproline in -Xaa-Pro- Gly- sequences in collagens, especially types IV and V. May be involved in the secretory pathway of cells. Has growth suppressive activity in fibroblasts.
Specifications
Specifications
| Accession Number | Q32P28 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 64175 |
| Name | Human LEPRE1 (aa 156-290) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | GROS1; Growth suppressor 1; LEPRE1; leprecan; Leprecan-1; leucine- and proline-enriched proteoglycan 1; leucine proline-enriched proteoglycan (leprecan) 1; OI8; P3H1; procollagen-proline 3-dioxygenase; prolyl 3-hydroxylase 1; PSEC0109 |
| Common Name | LEPRE1 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction